💊

Thiotepa Riemser

thiotepa

Przeszczepienie komórek macierzystych krwiotwórczych;Nowotwory

✅ Upoważniony Ogólny

✅

Brak aktywnych alertów

Ten lek nie jest objęty bieżącymi niedoborami, listami ostrzegawczymi ani wycofany z rynku.

Do czego to służy

Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients. Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients

⚠️ Bezpieczeństwo pacjenta

Oficjalna strona EMA

https://www.ema.europa.eu/en/medicines/human/EPAR/thiotepa-riemser